← FDA DRUG APPROVALS
FDA ANDA · ANDA201049
PIOGLITAZONE HYDROCHLORIDE AND GLIMEPIRIDE
Sponsor: CHARTWELL RX
APPLICATION
ANDA201049
TYPE
ANDA
ORIGINAL APPROVAL
2013-01-04
LATEST ACTION
2020-02-24
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription
Products
PIOGLITAZONE HYDROCHLORIDE AND GLIMEPIRIDEPrescription
GLIMEPIRIDE 4MG, PIOGLITAZONE HYDROCHLORIDE 30MG · TABLET · ORAL
PIOGLITAZONE HYDROCHLORIDE AND GLIMEPIRIDEPrescription
GLIMEPIRIDE 2MG, PIOGLITAZONE HYDROCHLORIDE 30MG · TABLET · ORAL
Approval history
2020-02-24Labeling · Supplement 7 · standardAP
2020-02-24Labeling · Supplement 8 · standardAP
2015-07-23Labeling · Supplement 5 · standardAP
2015-07-23Labeling · Supplement 4 · standardAP
2015-06-02Labeling · Supplement 1 · standardAP
2013-01-04Not Applicable · OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.